VNTA Stock Chart & Stats
$0.04
>-$0.01(-72.22%)
At close: 4:00 PM EST
$0.04
>-$0.01(-72.22%)
Day’s Range― - ―
52-Week Range$0.02 - $0.08
Previous CloseN/A
Volume2.10K
Average Volume (3M)6.75K
Market Cap
$1.77M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)20.6
Beta-3.65
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding53,783,543
10 Day Avg. Volume20,218
30 Day Avg. Volume6,753
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
VNTA FAQ
What was Ventana Global’s price range in the past 12 months?
Ventana Global lowest stock price was $0.02 and its highest was $0.08 in the past 12 months.
What is Ventana Global’s market cap?
Ventana Global’s market cap is $1.77M.
When is Ventana Global’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Ventana Global’s earnings last quarter?
Currently, no data Available
Is Ventana Global overvalued?
According to Wall Street analysts Ventana Global’s price is currently Overvalued.
Does Ventana Global pay dividends?
Ventana Global does not currently pay dividends.
What is Ventana Global’s EPS estimate?
Ventana Global’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Ventana Global have?
Ventana Global has 53,783,543 shares outstanding.
What happened to Ventana Global’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Ventana Global?
Currently, no hedge funds are holding shares in VNTA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Ventana Global
Ventana Biotech, Inc. is an emerging biotechnology enterprise focused on the lifecycle of drug candidates for personalized medicine, encompassing the identification, assessment, acquisition, development, and eventual commercialization through partnerships of relevant intellectual property. The company's primary therapeutic area is addressing obesity and its associated medical conditions. Notably, Ventana holds proprietary rights to a medicated chewing gum formulation that integrates an extract of hoodia gordonii and 2-hydroxyoleic acid. This unique composition is intended for the management of obesity, hypertension, and various other metabolic disorders. Ventana is actively engaged in developing these appetite-suppressant chewing gums into distinct products: a lower-dosage version aimed at the over-the-counter market, and a higher-dosage variant slated for distribution via pharmacists. The lower-strength product is expected to be retailed in drugstores and health food establishments. Established in 1989, Ventana Biotech, Inc. operates from Butschwil, Switzerland. The company adopted its current name in October 2008, having previously been known as Personalica, Inc.